CELZ
HEALTHCARECreative Medical Technology Holdings Inc
$2.23+0.00 (+0.00%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving CELZ Today?
No stock-specific AI insight has been generated for CELZ yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.50$6.25
$2.23
Fundamentals
Market Cap$8M
P/E Ratio—
EPS$-2.52
Dividend Yield—
Dividend / Share—
ROE-0.9%
Profit Margin—
Debt / Equity—
Trading
Volume94K
Avg Volume (10D)—
Shares Outstanding3.7M
CELZ News
18 articles- Creative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome™ Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell-Free Regenerative TherapiesYahoo Finance·Apr 28, 2026
- Analysts Expect Breakeven For Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Before LongYahoo Finance·Apr 9, 2026
- Creative Medical Technology Holdings Achieves Second WHO INN Milestone, Strengthening Global Regulatory Positioning Across Expanding Cell Therapy PipelineYahoo Finance·Feb 10, 2026
- Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back PainYahoo Finance·Jan 13, 2026
- Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit InitiativeYahoo Finance·Jan 6, 2026
- Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection PointYahoo Finance·Dec 17, 2025
- Creative Medical Technology Holdings Announces World Health Organization Approval of “olastrocel” as INN for Lead Allogeneic Cell Therapy CELZ-201Yahoo Finance·Dec 2, 2025
- Bears are Losing Control Over Creative Medical Technology Holdings, Inc. (CELZ), Here's Why It's a 'Buy' NowYahoo Finance·Nov 5, 2025
- Market Sentiment Around Loss-Making Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ)Yahoo Finance·Oct 31, 2025
- Creative Medical Technology Holdings, Inc. Ignites Next-Gen Regenerative BioDefense Initiative for U.S. Veterans Exposed to Burn PitsYahoo Finance·Oct 30, 2025
- Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.2 Million Gross ProceedsYahoo Finance·Oct 29, 2025
- Creative Medical Technology Holdings Issues Letter to ShareholdersYahoo Finance·Oct 27, 2025
- Creative Medical Technology Holdings Congratulates 2025 Nobel Laureates for Regulatory T Cell BreakthroughsYahoo Finance·Oct 7, 2025
- Creative Medical Technology Holdings Secures FDA Fast Track Designation for CELZ-201-DDT - Advancing Breakthrough Therapy for Chronic Lower Back PainYahoo Finance·Aug 13, 2025
- Creative Medical Technology Holdings Second Quarter 2025 Earnings: US$0.48 loss per share (vs US$1.11 loss in 2Q 2024)Yahoo Finance·Aug 11, 2025
- New Strong Sell Stocks for July 31stYahoo Finance·Jul 31, 2025
- Creative Medical Technology Holdings Receives Notice of Allowance for the Prevention and/or Treatment of Type 1 Diabetes Using Modulated Immune CellsYahoo Finance·Jul 17, 2025
- Creative Medical Technology Holdings Receives Notice of Allowance for ImmCelz™ for Treatment of Heart Failure and/or Post Infarct Pathological RemodelingYahoo Finance·Jul 11, 2025
All 18 articles loaded
Price Data
Open$2.20
Previous Close$2.23
Day High$2.33
Day Low$2.19
52 Week High$6.25
52 Week Low$1.50
52-Week Range
$1.50$6.25
$2.23
Fundamentals
Market Cap$8M
P/E Ratio—
EPS$-2.52
Dividend Yield—
Dividend / Share—
ROE-0.9%
Profit Margin—
Debt / Equity—
Trading
Volume94K
Avg Volume (10D)—
Shares Outstanding3.7M
About Creative Medical Technology Holdings Inc
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company is headquartered in Phoenix, Arizona.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—